Code | CSB-MA0026131A0m |
Size | US$210 |
Order now | |
Image |
|
Have Questions? | Leave a Message or Start an on-line Chat |
Application | Recommended Dilution |
---|---|
WB | 1:500-1:5000 |
IHC | 1:50-1:500 |
The BCL2L1 monoclonal antibody is produced through the process of immunizing mice with recombinant human BCL2L1 protein, followed by the isolation of B cells from the mouse spleen and fusion of these B cells with myeloma cells to form hybridomas. The hybridomas that produce the BCL2L1 antibody are selected to be cultured in the mouse abdominal cavity, and the BCL2L1 monoclonal antibodies are collected from the mouse ascites. This BCL2L1 monoclonal antibody reacts specifically with human BCL2L1 protein in ELISA, WB, and IHC applications. It is purified using protein G affinity chromatography, resulting in a purity of over 95%.
BCL2L1 plays an important role in regulating apoptosis. It is also involved in maintaining mitochondrial homeostasis and regulating cellular metabolism, particularly in cancer cells. Dysregulation of BCL2L1 expression or activity has been implicated in various human diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.
There are currently no reviews for this product.